Product Center
On February 23, 2016, Contract Signed Between Ab&B Bio-Tech and China Medical City
- Categories:Industry news
- Author:
- Origin:
- Time of issue:2016-02-23
- Views:
(Summary description)On February 23, 2016, contract signed between Ab&B Bio-Tech and China Medical City
On February 23, 2016, Contract Signed Between Ab&B Bio-Tech and China Medical City
(Summary description)On February 23, 2016, contract signed between Ab&B Bio-Tech and China Medical City
- Categories:Industry news
- Author:
- Origin:
- Time of issue:2016-02-23 10:57
- Views:
Information
Scan the QR code to read on your phone
Next:
None
Relevant information
-
The Launch Meeting of Phase I/II Clinical Trial for Recombinant Herpes Zoster Vaccine (CHO Cell) was successfully heldRecently, the Phase I/II clinical trial launch meeting for the recombinant herpes zoster vaccine (CHO cell), co-developed by Ab&B Bio-Tech CO., LTD. JS. and Yither Biotech (Shanghai) Co., Ltd., was successfully held in Henan, and the first-in-human (FIH) dosing was successfully completed. - Ab&B Bio and Yither Bio Have Both Obtained Qualification Certification! 12-30
- Kickoff Meeting for Clinical Research on Quadrivalent Influenza Virus Subunit Vaccine in Children with Nephrotic Syndrome Successfully Held 12-25
- IND Application for Influenza Virus Subunit Vaccine (Adjuvanted) Approved 10-30
- The Application for the Marketing of Trivalent Influenza Virus Subunit Vaccine has been Accepted! 10-08
Got a project? Contact us today !
At Ab&B Bio, our mission is to care for life and protect health by developing globally innovative vaccines.
Contact
E-mail:haixin.zhang@yitherbiotech.com
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City
Quick view
Follow us
